Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,922.50 -15.50 (-0.80%)

Bid:

1,922.00

Ask:

1,923.00

Spread: 1.00 (0.052%)

Market Cap: £77.10b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

GSK moves towards clearance of two new drugs in China and Japan

(Alliance News) - GSK PLC on Thursday reported positive regulatory momentum in Japan and China, where two of its drugs have been accepted for review.

Pharmaceuticals

GSK secures Japan and China reviews for two late‑stage liver disease treatments

(Sharecast News) - Drugmaker GSK said on Thursday that regulators in Japan and China had accepted two separate new drug applications for review, cover...

GSK to buy 35Pharma for $950 million in CEO Miel's second major deal

Feb 25 (Reuters) - GSK has agreed to pay $950 million ⁠in cash for Canadian biotech 35Pharma, it said ⁠on Wednesday, marking the second major deal ne...

Corporate News

GSK buys Canadian biopharmaceutical firm 35Pharma for USD950 million

(Alliance News) - GSK PLC on Wednesday said it has agreed to buy Canada-based clinical stage biopharmaceutical firm 35Pharma Inc for USD950 million in...

Corporate News

GSK to acquire Canada's 35Pharma for $950m

(Sharecast News) - Drugmaker GSK has agreed to acquire Canadian clinical-stage biopharmaceutical firm 35Pharma for $950m in cash.

LONDON MARKET OPEN: Stocks fall after latest tariff salvo

(Alliance News) - Stock prices in Europe moved lower in early dealings on Monday, with enthusiasm at the start of the week tempered by tariff uncertai...

IN BRIEF: GSK non-executive director buys nearly GBP75,000 in shares

GSK PLC - London-based pharmaceuticals company - Independent Non-Executive Director Wendy Becker buys 3,334 shares, at GBP22.19, worth GBP73,990, on F...

LONDON BROKER RATINGS: Shore raises Sage, UBS raises St James's Place

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: